Data: 9 May 2026

Flagged for Manual Review

Round 3 merged 7 different OpenAlex profiles by name match alone (unverified)

Metrics shown are from the primary verified profile.7 name-matched profiles were discovered and excluded from these metrics.

John Estell

Published as: Jane Estell

NSW, Australia · RMSANZ Member (Ordinary Membership) · FAFRM

Institution(s): AU

MM 1 - Metropolitan(Postcode: 2139)

Genetics and molecular biologySpinal cord injury rehabilitationTrauma rehabilitationCancer rehabilitationDigital health and AI in rehabilitation

Clinical Expertise (self-reported)

NeurorehabilitationMusculoskeletal rehabilitationStroke rehabilitationTrauma rehabilitationAmputation, prosthetics and orthoticsCancer rehabilitationSpasticity managementAdults with childhood-onset disabilitiesRehabilitation pathways and service modelsHealth services researchHealth policy and advocacy

Research Expertise (self-reported)

Spasticity managementRehabilitation pathways and service modelsHealth services researchHealth policy and advocacy

Source: RMSANZ Member Survey 2025 (Chapter 3)

12

H-index

41

Publications

2,289

Citations

28.73

FWCI

44

Funding Awards

0

Clinical Trials

Publication Timeline

Click a bar to filter publications by year

Co-Author Network

4 collaborators · Node size = shared publications

Collaborator	Shared Pubs	Profile
John Olver	1	View
Steven Faux	1	View
Senen Gonzalez	1	View
Ian Baguley	1	View

Funding Awards (44)

Carfilzomib, thalidomide, and dexamethasone is safe and effective in relapsed and/or refractory multiple myeloma: final report of the single arm, multicenter phase II ALLG MM018/AMN002 study.

Amgen · 2024

Phase I Study of Safety and Pharmacokinetics of RO7297089, an Anti-BCMA/CD16a Bispecific Antibody, in Patients with Relapsed, Refractory Multiple Myeloma

Genentech · 2023

Challenges associated with test dose pharmacokinetic predictions of high dose melphalan exposure in patients with multiple myeloma

Australian Government · 2022

Challenges associated with test dose pharmacokinetic predictions of high dose melphalan exposure in patients with multiple myeloma

University of Sydney · 2022

Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14)

Amgen · 2021

Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14)

Pfizer · 2021

Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14)

Novartis · 2021

Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14)

Sanofi · 2021

Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14)

Celgene · 2021

Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14)

University of Otago · 2021

Identifiers & Metadata

Profile ID:A5064831033

ORCID:0000-0001-6419-6821

Alt. IDs:

A5008303766 A5016149761 A5025167887 A5036176377 A5111427575 A5112633906

Confidence:REVIEW

Collaborators:4

Verification:Original REVIEW match not verified in Round 2 due to batch coverage. IDs retained pending manual review.

Publications (41 shown of 41 total)

Trends in Race/Ethnicity Among Applicants and Matriculants to US Surgical Specialties, 2010-2018

JAMA Network Open · 2020 · 136 citations

Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS)

Leukemia · 2020 · 97 citations

Using Rubrics For The Assessment Of Senior Design Projects

Papers on Engineering Education Repository (American Society for Engineering Education) · 2020 · 41 citations

Beef Production in the Southwestern United States: Strategies Toward Sustainability

Frontiers in Sustainable Food Systems · 2020 · 34 citations

Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study

Journal of Clinical Oncology · 2019 · 274 citations

Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Patients With Previously Treated Multiple Myeloma: Three-year Follow-up of CASTOR

Clinical Lymphoma Myeloma & Leukemia · 2019 · 150 citations

Synthesis Paper: Targeted Livestock Grazing: Prescription for Healthy Rangelands

Rangeland Ecology & Management · 2019 · 101 citations

Seasonal Divergence of Landscape Use by Heritage and Conventional Cattle on Desert Rangeland

Rangeland Ecology & Management · 2019 · 48 citations

Long-Term Declining Trends in Chihuahuan Desert Forage Production in Relation to Precipitation and Ambient Temperature

Rangeland Ecology & Management · 2019 · 36 citations

Efficacy and Safety of Daratumumab, Bortezomib, and Dexamethasone (D-Vd) Versus Bortezomib and Dexamethasone (Vd) in First Relapse Patients (pts) with Multiple Myeloma (MM): Four-Year Update of Castor

Blood · 2019 · 32 citations